{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T02:10:44Z","timestamp":1774923044774,"version":"3.50.1"},"reference-count":180,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,6,9]],"date-time":"2025-06-09T00:00:00Z","timestamp":1749427200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,6,9]],"date-time":"2025-06-09T00:00:00Z","timestamp":1749427200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s11033-025-10671-4","type":"journal-article","created":{"date-parts":[[2025,6,9]],"date-time":"2025-06-09T03:27:44Z","timestamp":1749439664000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Targeting neurotrophic dysregulation in diabetic retinopathy: a novel therapeutic avenue"],"prefix":"10.1007","volume":"52","author":[{"given":"Divya","family":"Rana","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sanchit","family":"Dhankhar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rupali","family":"Chauhan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Monika","family":"Saini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Randhir","family":"Singh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Parveen","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thakur Gurjeet","family":"Singh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samrat","family":"Chauhan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sushma","family":"Devi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,6,9]]},"reference":[{"issue":"14","key":"10671_CR1","doi-asserted-by":"crossref","first-page":"3945","DOI":"10.3390\/jcm11143945","volume":"11","author":"H Al Zabadi","year":"2022","unstructured":"Al Zabadi H, Taha I, Zagha R (2022) Clinical and molecular characteristics of diabetic retinopathy and its severity complications among diabetic patients: a multicenter cross-sectional study. J Clin Med 11(14):3945","journal-title":"J Clin Med"},{"key":"10671_CR2","doi-asserted-by":"crossref","first-page":"115881","DOI":"10.1016\/j.biopha.2023.115881","volume":"169","author":"M Rohilla","year":"2023","unstructured":"Rohilla M et al (2023) Discussing pathologic mechanisms of diabetic retinopathy & therapeutic potentials of Curcumin and \u03b2-glucogallin in the management of diabetic retinopathy. Biomed Pharmacother 169:115881","journal-title":"Biomed Pharmacother"},{"key":"10671_CR3","doi-asserted-by":"crossref","unstructured":"Bosma EK et al (2019) Microvascular complications in the eye: diabetic retinopathy. Diabetic Nephropathy: Pathophysiology and Clinical Aspects pp. 305\u2013321","DOI":"10.1007\/978-3-319-93521-8_19"},{"key":"10671_CR4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2174\/0122115501303253240408072559","volume":"13","author":"S Dhankhar","year":"2024","unstructured":"Dhankhar S et al (2024) Role of artificial intelligence in diabetic wound screening and early detection. Curr Biotechnol 13:1\u201314","journal-title":"Curr Biotechnol"},{"issue":"2","key":"10671_CR5","doi-asserted-by":"crossref","first-page":"117","DOI":"10.2174\/1570161117666190502103733","volume":"18","author":"C Faselis","year":"2020","unstructured":"Faselis C et al (2020) Microvascular complications of type 2 diabetes mellitus. Curr Vasc Pharmacol 18(2):117\u2013124","journal-title":"Curr Vasc Pharmacol"},{"issue":"6","key":"10671_CR6","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1111\/dme.12089","volume":"30","author":"L Heng","year":"2013","unstructured":"Heng L et al (2013) Diabetic retinopathy: pathogenesis, clinical grading, management and future developments. Diabet Med 30(6):640\u2013650","journal-title":"Diabet Med"},{"issue":"4","key":"10671_CR7","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.sjopt.2010.06.003","volume":"24","author":"A Pai","year":"2010","unstructured":"Pai A et al (2010) Current concepts in intravitreal drug therapy for diabetic retinopathy. Saudi J Ophthalmol 24(4):143\u2013149","journal-title":"Saudi J Ophthalmol"},{"issue":"16","key":"10671_CR8","doi-asserted-by":"crossref","first-page":"333","DOI":"10.4239\/wjd.v7.i16.333","volume":"7","author":"MW Stewart","year":"2016","unstructured":"Stewart MW (2016) Treatment of diabetic retinopathy: recent advances and unresolved challenges. World J Diabetes 7(16):333","journal-title":"World J Diabetes"},{"key":"10671_CR9","doi-asserted-by":"crossref","unstructured":"Abhishek C et al (2025) Serotonergic dynamics in autism spectrum disorder: unraveling the intricate connection. CNS & neurological Disorders - Drug targets. 24:1\u201310","DOI":"10.2174\/0118715273378214250213114328"},{"issue":"15","key":"10671_CR10","doi-asserted-by":"crossref","first-page":"8513","DOI":"10.3390\/ijms23158513","volume":"23","author":"R Sim\u00f3","year":"2022","unstructured":"Sim\u00f3 R, Hern\u00e1ndez C (2022) New insights into treating early and advanced stage diabetic retinopathy. Int J Mol Sci 23(15):8513","journal-title":"Int J Mol Sci"},{"issue":"4","key":"10671_CR11","doi-asserted-by":"crossref","first-page":"942","DOI":"10.3390\/ijms19040942","volume":"19","author":"A R\u00fcbsam","year":"2018","unstructured":"R\u00fcbsam A, Parikh S, Fort PE (2018) Role of inflammation in diabetic retinopathy. Int J Mol Sci 19(4):942","journal-title":"Int J Mol Sci"},{"issue":"1","key":"10671_CR12","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s13098-023-00983-5","volume":"15","author":"S Dhankhar","year":"2023","unstructured":"Dhankhar S et al (2023) Novel targets for potential therapeutic use in diabetes mellitus. Diabetol Metab Syndr 15(1):17","journal-title":"Diabetol Metab Syndr"},{"key":"10671_CR13","doi-asserted-by":"crossref","first-page":"119311","DOI":"10.1016\/j.lfs.2021.119311","volume":"273","author":"A Arora","year":"2021","unstructured":"Arora A et al (2021) Unravelling the involvement of gut microbiota in type 2 diabetes mellitus. Life Sci 273:119311","journal-title":"Life Sci"},{"issue":"10","key":"10671_CR14","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1136\/bjophthalmol-2012-302005","volume":"96","author":"R Sim\u00f3","year":"2012","unstructured":"Sim\u00f3 R, Hern\u00e1ndez C (2012).f.t.E.T.o.D. Retinopathy, neurodegeneration is an early event in diabetic retinopathy: therapeutic implications. Br J Ophthalmol 96(10):1285\u20131290","journal-title":"Br J Ophthalmol"},{"issue":"5","key":"10671_CR15","doi-asserted-by":"crossref","first-page":"364","DOI":"10.4093\/dmj.2018.0182","volume":"42","author":"S Kusuhara","year":"2018","unstructured":"Kusuhara S et al (2018) Pathophysiology of diabetic retinopathy: the old and the new. Diabetes Metabolism J 42(5):364","journal-title":"Diabetes Metabolism J"},{"issue":"4","key":"10671_CR16","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1038\/s41574-020-00451-4","volume":"17","author":"DA Antonetti","year":"2021","unstructured":"Antonetti DA, Silva PS, Stitt AW (2021) Current Understanding of the molecular and cellular pathology of diabetic retinopathy. Nat Reviews Endocrinol 17(4):195\u2013206","journal-title":"Nat Reviews Endocrinol"},{"key":"10671_CR17","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.visres.2017.04.003","volume":"139","author":"J Lechner","year":"2017","unstructured":"Lechner J, O\u2019Leary OE, Stitt AW (2017) The pathology associated with diabetic retinopathy. Vision Res 139:7\u201314","journal-title":"Vision Res"},{"issue":"1","key":"10671_CR18","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1089\/jop.2023.0068","volume":"40","author":"A Biswas","year":"2024","unstructured":"Biswas A et al (2024) Recent insights into the etiopathogenesis of diabetic retinopathy and its management. J Ocul Pharmacol Ther 40(1):13\u201333","journal-title":"J Ocul Pharmacol Ther"},{"issue":"2","key":"10671_CR19","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1007\/s10787-023-01143-x","volume":"31","author":"A Sood","year":"2023","unstructured":"Sood A et al (2023) Exploring various novel diagnostic and therapeutic approaches in treating diabetic retinopathy. Inflammopharmacology 31(2):773\u2013786","journal-title":"Inflammopharmacology"},{"key":"10671_CR20","unstructured":"Firdous S et al (2021) Diabetic retinopathy: pathogenesis and therapeutic management. Diabetes Diabet Complications p. 123\u2013140"},{"issue":"3","key":"10671_CR21","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.3390\/ijms25031618","volume":"25","author":"FJ Romero","year":"2024","unstructured":"Romero FJ et al (2024) Small extracellular vesicles and oxidative pathophysiological mechanisms in retinal degenerative diseases. Int J Mol Sci 25(3):1618","journal-title":"Int J Mol Sci"},{"issue":"3","key":"10671_CR22","doi-asserted-by":"crossref","first-page":"219","DOI":"10.14715\/cmb\/2024.70.3.33","volume":"70","author":"J Zhou","year":"2024","unstructured":"Zhou J et al (2024) Molecular mechanism of high glucose-induced mitochondrial DNA damage in retinal ganglion cells. Cell Mol Biol 70(3):219\u2013224","journal-title":"Cell Mol Biol"},{"key":"10671_CR23","doi-asserted-by":"crossref","first-page":"117658","DOI":"10.1016\/j.jep.2023.117658","volume":"323","author":"J Li","year":"2024","unstructured":"Li J et al (2024) Exploring the mechanism of Bushen Huoxue prescription in the treatment of early diabetic retinal edema from the perspective of inner blood-retinal barrier injury. J Ethnopharmacol 323:117658","journal-title":"J Ethnopharmacol"},{"key":"10671_CR24","doi-asserted-by":"crossref","unstructured":"Yuan D et al (2024) Resveratrol protects against diabetic retinal ganglion cell damage by activating the Nrf2 signaling pathway. Heliyon","DOI":"10.1016\/j.heliyon.2024.e30786"},{"key":"10671_CR25","unstructured":"Khaled WGMTH, Abdel-Maksouda HAFM (2024) Morphological and Immunohistochemical Differentiation of Neuronal and Glial Cells of the Vascular and Avascular Regions of the DonkeyLs Paurangiotic Retina"},{"issue":"1","key":"10671_CR26","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1186\/s12974-024-03058-y","volume":"21","author":"RA Shahror","year":"2024","unstructured":"Shahror RA et al (2024) Role of myeloid cells in ischemic retinopathies: recent advances and unanswered questions. J Neuroinflamm 21(1):65","journal-title":"J Neuroinflamm"},{"key":"10671_CR27","doi-asserted-by":"crossref","unstructured":"Li J, Zhao T, Sun Y (2024) Interleukin-17A in diabetic retinopathy: the crosstalk of inflammation and angiogenesis. Biochem Pharmacol p. 116311","DOI":"10.1016\/j.bcp.2024.116311"},{"key":"10671_CR28","doi-asserted-by":"crossref","unstructured":"Sim\u00f3 R (2024) Retinal neurodegeneration: importance in diabetes management. Chronic complications of diabetes mellitus. Elsevier pp 101\u2013115","DOI":"10.1016\/B978-0-323-88426-6.00002-6"},{"issue":"4","key":"10671_CR29","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1111\/febs.16330","volume":"290","author":"F O\u2019Leary","year":"2023","unstructured":"O\u2019Leary F, Campbell M (2023) The blood\u2013retina barrier in health and disease. FEBS J 290(4):878\u2013891","journal-title":"FEBS J"},{"issue":"20","key":"10671_CR30","doi-asserted-by":"crossref","first-page":"2443","DOI":"10.3390\/cells12202443","volume":"12","author":"K Bora","year":"2023","unstructured":"Bora K et al (2023) Assessment of inner Blood\u2013Retinal barrier: animal models and methods. Cells 12(20):2443","journal-title":"Cells"},{"issue":"2","key":"10671_CR31","doi-asserted-by":"crossref","first-page":"380","DOI":"10.18006\/2023.11(2).380.393","volume":"11","author":"MS Ahmed","year":"2023","unstructured":"Ahmed MS et al (2023) Phytochemical investigations, in-vitro antioxidant, antimicrobial potential, and in-silico computational Docking analysis of Euphorbia milii des moul. J Experimental Biology Agricultural Sci 11(2):380\u2013393","journal-title":"J Experimental Biology Agricultural Sci"},{"key":"10671_CR32","unstructured":"Zhang J et al (2023) Effects of water-sodium balance and regulation of electrolytes associated with antidiabetic drugs. Eur Rev Med Pharmacol Sci 27(12)"},{"issue":"1","key":"10671_CR33","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/s40942-024-00556-2","volume":"10","author":"R Al-Dwairi","year":"2024","unstructured":"Al-Dwairi R et al (2024) Vitreous levels of pigment epithelium-derived factor and vascular endothelial growth factor in diabetic and non-diabetic retinopathy: associated factors and anatomical correlation. Int J Retina Vitreous 10(1):38","journal-title":"Int J Retina Vitreous"},{"key":"10671_CR34","doi-asserted-by":"crossref","unstructured":"Calcutt NA (2023) Neurotrophic factors in the pathogenesis and treatment of diabetic neuropathy, in diabetic neuropathy: advances in pathophysiology and clinical management. Springer, pp 127\u2013155","DOI":"10.1007\/978-3-031-15613-7_8"},{"key":"10671_CR35","doi-asserted-by":"crossref","unstructured":"Subramani M, Van Hook MJ, Ahmad I (2023) Reproducible generation of human retinal ganglion cells from banked retinal progenitor cells: analysis of target recognition and IGF-1-mediated axon regeneration. Front Cell Dev Biology 11","DOI":"10.3389\/fcell.2023.1214104"},{"key":"10671_CR36","unstructured":"Petridou E (2023) Investigating terminal divisions during retinal development in zebrafish. lmu"},{"issue":"7","key":"10671_CR37","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.3390\/genes14071325","volume":"14","author":"M Toms","year":"2023","unstructured":"Toms M, Ward N, Moosajee M (2023) Nuclear receptor subfamily 2 group E member 3 (NR2E3): role in retinal development and disease. Genes 14(7):1325","journal-title":"Genes"},{"issue":"6","key":"10671_CR38","doi-asserted-by":"crossref","first-page":"705","DOI":"10.3390\/genes15060705","volume":"15","author":"KE Ashworth","year":"2024","unstructured":"Ashworth KE, Weisbrod J, Ballios BG (2024) Inherited retinal diseases and retinal organoids as preclinical cell models for inherited retinal disease research. Genes 15(6):705","journal-title":"Genes"},{"key":"10671_CR39","unstructured":"Zelko S (2023) Assessing a novel synthetic FZD4 agonist to rescue blood brain barrier dysfunction. University of Toronto (Canada)"},{"issue":"5","key":"10671_CR40","doi-asserted-by":"crossref","first-page":"976","DOI":"10.4103\/1673-5374.355743","volume":"18","author":"L Tang","year":"2023","unstructured":"Tang L, Xu G-T, Zhang J-F (2023) Inflammation in diabetic retinopathy: possible roles in pathogenesis and potential implications for therapy. Neural Regeneration Res 18(5):976\u2013982","journal-title":"Neural Regeneration Res"},{"key":"10671_CR41","doi-asserted-by":"crossref","first-page":"1225373","DOI":"10.3389\/fnmol.2023.1225373","volume":"16","author":"S Ateaque","year":"2023","unstructured":"Ateaque S, Merkouris S, Barde Y-A (2023) Neurotrophin signalling in the human nervous system. Front Mol Neurosci 16:1225373","journal-title":"Front Mol Neurosci"},{"issue":"8","key":"10671_CR42","doi-asserted-by":"crossref","first-page":"4206","DOI":"10.1007\/s12035-023-03328-5","volume":"60","author":"MM Rahman","year":"2023","unstructured":"Rahman MM et al (2023) Exploring the therapeutic effect of neurotrophins and neuropeptides in neurodegenerative diseases: at a glance. Mol Neurobiol 60(8):4206\u20134231","journal-title":"Mol Neurobiol"},{"issue":"1","key":"10671_CR43","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1038\/s41420-023-01717-2","volume":"9","author":"J Li","year":"2023","unstructured":"Li J et al (2023) Mechanistic insights into the alterations and regulation of the AKT signaling pathway in diabetic retinopathy. Cell Death Discovery 9(1):418","journal-title":"Cell Death Discovery"},{"key":"10671_CR44","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2174\/187152732301230726152502","volume":"23","author":"S Dhankar","year":"2024","unstructured":"Dhankar S et al (2024) Artificial intelligence in the management of neurodegenerative disorders. CNS Neurol Disorders - Drug Targets 23:1\u201310","journal-title":"CNS Neurol Disorders - Drug Targets"},{"issue":"20","key":"10671_CR45","doi-asserted-by":"crossref","first-page":"15359","DOI":"10.3390\/ijms242015359","volume":"24","author":"LI Benowitz","year":"2023","unstructured":"Benowitz LI, Xie L, Yin Y (2023) Inflammatory mediators of axon regeneration in the central and peripheral nervous systems. Int J Mol Sci 24(20):15359","journal-title":"Int J Mol Sci"},{"key":"10671_CR46","doi-asserted-by":"crossref","unstructured":"Bothwell M (2019) Recent advances in Understanding context-dependent mechanisms controlling neurotrophin signaling and function. F1000Research, p 8","DOI":"10.12688\/f1000research.19174.1"},{"issue":"2","key":"10671_CR47","doi-asserted-by":"crossref","first-page":"fcad046","DOI":"10.1093\/braincomms\/fcad046","volume":"5","author":"A Want","year":"2023","unstructured":"Want A et al (2023) Brain-derived neurotrophic factor released from blood platelets prevents dendritic atrophy of lesioned adult central nervous system neurons. Brain Commun 5(2):fcad046","journal-title":"Brain Commun"},{"issue":"8","key":"10671_CR48","doi-asserted-by":"crossref","first-page":"7089","DOI":"10.3390\/ijms24087089","volume":"24","author":"S Manti","year":"2023","unstructured":"Manti S et al (2023) Neurotrophins: expression of brain\u2013lung axis development. Int J Mol Sci 24(8):7089","journal-title":"Int J Mol Sci"},{"issue":"4","key":"10671_CR49","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1093\/humupd\/dmaa008","volume":"26","author":"R Chow","year":"2020","unstructured":"Chow R, Wessels J, Foster W (2020) Brain-derived neurotrophic factor (BDNF) expression and function in the mammalian reproductive tract. Hum Reprod Update 26(4):545\u2013564","journal-title":"Hum Reprod Update"},{"key":"10671_CR50","unstructured":"Popa LL et al (2023) The modulation of Hippocampus plasticity, in Hippocampus-More than Just Memory. IntechOpen"},{"issue":"3\u20134","key":"10671_CR51","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1080\/08977194.2020.1864347","volume":"38","author":"NA Ismail","year":"2020","unstructured":"Ismail NA et al (2020) A narrative review of brain-derived neurotrophic factor (BDNF) on cognitive performance in alzheimer\u2019s disease. Growth Factors 38(3\u20134):210\u2013225","journal-title":"Growth Factors"},{"issue":"7","key":"10671_CR52","doi-asserted-by":"crossref","first-page":"908","DOI":"10.3390\/ph16070908","volume":"16","author":"P Mittal","year":"2023","unstructured":"Mittal P et al (2023) A review on natural antioxidants for their role in the treatment of parkinson\u2019s disease. Pharmaceuticals 16(7):908","journal-title":"Pharmaceuticals"},{"issue":"2","key":"10671_CR53","doi-asserted-by":"crossref","first-page":"e0268816","DOI":"10.1371\/journal.pone.0268816","volume":"18","author":"F Moosaie","year":"2023","unstructured":"Moosaie F et al (2023) Brain-derived neurotrophic factor in diabetes mellitus: A systematic review and meta-analysis. PLoS ONE 18(2):e0268816","journal-title":"PLoS ONE"},{"key":"10671_CR54","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2174\/2666082219666230320153841","volume":"20","author":"S Dhankhar","year":"2024","unstructured":"Dhankhar S et al (2024) Cognitive rehabilitation for Early-Stage dementia: A review. Curr Psychiatry Res Reviews 20:1\u201314","journal-title":"Curr Psychiatry Res Reviews"},{"issue":"3","key":"10671_CR55","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1002\/dmrr.290","volume":"18","author":"T Nakagawa","year":"2002","unstructured":"Nakagawa T et al (2002) Brain-derived neurotrophic factor (BDNF) regulates glucose and energy metabolism in diabetic mice. Diab\/Metab Res Rev 18(3):185\u2013191","journal-title":"Diab\/Metab Res Rev"},{"issue":"1","key":"10671_CR56","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s13020-023-00725-9","volume":"18","author":"F Sanie-Jahromi","year":"2023","unstructured":"Sanie-Jahromi F, Zia Z, Afarid M (2023) A review on the effect of Garlic on diabetes, BDNF, and VEGF as a potential treatment for diabetic retinopathy. Chin Med 18(1):18","journal-title":"Chin Med"},{"key":"10671_CR57","unstructured":"Saboowala H (2022) Exploring the clinical implications of Brain-derived neurotrophic factor (BDNF). Dr. Hakim Saboowala"},{"key":"10671_CR58","doi-asserted-by":"crossref","unstructured":"Sharma E et al (2021) Exploring the various aspects of brain-derived neurotropic factor (BDNF) in diabetes mellitus. CNS & neurological Disorders-Drug targets (Formerly current drug targets-CNS & neurological Disorders) 20(1):22\u201333","DOI":"10.2174\/1871527319666201014125642"},{"issue":"7","key":"10671_CR59","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.tins.2012.03.007","volume":"35","author":"CF Ib\u00e1\u00f1ez","year":"2012","unstructured":"Ib\u00e1\u00f1ez CF, Simi A (2012) p75 neurotrophin receptor signaling in nervous system injury and degeneration: paradox and opportunity. Trends Neurosci 35(7):431\u2013440","journal-title":"Trends Neurosci"},{"issue":"31","key":"10671_CR60","doi-asserted-by":"crossref","first-page":"21205","DOI":"10.1074\/jbc.M114.563403","volume":"289","author":"BR Kraemer","year":"2014","unstructured":"Kraemer BR et al (2014) A role for the p75 neurotrophin receptor in axonal degeneration and apoptosis induced by oxidative stress. J Biol Chem 289(31):21205\u201321216","journal-title":"J Biol Chem"},{"issue":"3","key":"10671_CR61","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/S1734-1140(13)71031-4","volume":"65","author":"M Nowacka","year":"2013","unstructured":"Nowacka M, Obuchowicz E (2013) BDNF and VEGF in the pathogenesis of stress-induced affective diseases: an insight from experimental studies. Pharmacol Rep 65(3):535\u2013546","journal-title":"Pharmacol Rep"},{"key":"10671_CR62","doi-asserted-by":"crossref","unstructured":"Barker PA et al (2020) Nerve growth factor signaling and its contribution to pain. J Pain Res p. 1223\u20131241","DOI":"10.2147\/JPR.S247472"},{"key":"10671_CR63","doi-asserted-by":"crossref","unstructured":"Batool Z et al (2023) Receptor tyrosine kinases (RTKs): from biology to pathophysiology, in receptor tyrosine kinases in neurodegenerative and psychiatric disorders. Elsevier, pp 117\u2013185","DOI":"10.1016\/B978-0-443-18677-6.00012-9"},{"issue":"4","key":"10671_CR64","doi-asserted-by":"crossref","first-page":"3200","DOI":"10.3390\/ijms24043200","volume":"24","author":"F Bruno","year":"2023","unstructured":"Bruno F et al (2023) The nerve growth factor receptor (NGFR\/p75NTR): a major player in alzheimer\u2019s disease. Int J Mol Sci 24(4):3200","journal-title":"Int J Mol Sci"},{"key":"10671_CR65","unstructured":"Rosso P (2018) Role of Nerve Growth Factor (NGF) on mature and immature neurons in pathological conditions: effects of ocularly applied NGF"},{"issue":"7","key":"10671_CR66","doi-asserted-by":"crossref","first-page":"2351","DOI":"10.3390\/ijms21072351","volume":"21","author":"MC Potilinski","year":"2020","unstructured":"Potilinski MC et al (2020) Mechanisms behind retinal ganglion cell loss in diabetes and therapeutic approach. Int J Mol Sci 21(7):2351","journal-title":"Int J Mol Sci"},{"issue":"1","key":"10671_CR67","doi-asserted-by":"crossref","first-page":"50","DOI":"10.3746\/pnf.2022.27.1.50","volume":"27","author":"S Gupta","year":"2022","unstructured":"Gupta S et al (2022) Brassica oleracea extracts prevent hyperglycemia in type 2 diabetes mellitus. Prev Nutr Food Sci 27(1):50","journal-title":"Prev Nutr Food Sci"},{"issue":"15","key":"10671_CR68","doi-asserted-by":"crossref","first-page":"6767","DOI":"10.1167\/iovs.16-19747","volume":"57","author":"JH Park","year":"2016","unstructured":"Park JH et al (2016) Nerve growth factor attenuates apoptosis and inflammation in the diabetic cornea. Investig Ophthalmol Vis Sci 57(15):6767\u20136775","journal-title":"Investig Ophthalmol Vis Sci"},{"issue":"4","key":"10671_CR69","doi-asserted-by":"crossref","first-page":"889","DOI":"10.2337\/db07-1669","volume":"57","author":"TK Ali","year":"2008","unstructured":"Ali TK et al (2008) Peroxynitrite mediates retinal neurodegeneration by inhibiting nerve growth factor survival signaling in experimental and human diabetes. Diabetes 57(4):889\u2013898","journal-title":"Diabetes"},{"key":"10671_CR70","doi-asserted-by":"crossref","unstructured":"Hoz Monta\u00f1ana Rd et al (2016) Retinal Macroglial Responses in Health and Disease","DOI":"10.1155\/2016\/2954721"},{"issue":"12","key":"10671_CR71","doi-asserted-by":"crossref","first-page":"2214","DOI":"10.1136\/gutjnl-2018-317872","volume":"68","author":"L Tao","year":"2019","unstructured":"Tao L et al (2019) Glial cell line-derived neurotrophic factor (GDNF) mediates hepatic stellate cell activation via ALK5\/Smad signalling. Gut 68(12):2214\u20132227","journal-title":"Gut"},{"issue":"9","key":"10671_CR72","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.3390\/ijms17091584","volume":"17","author":"A Kimura","year":"2016","unstructured":"Kimura A et al (2016) Neuroprotection, growth factors and BDNF-TrkB signalling in retinal degeneration. Int J Mol Sci 17(9):1584","journal-title":"Int J Mol Sci"},{"issue":"4","key":"10671_CR73","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1007\/s10072-023-07253-2","volume":"45","author":"V Kakoty","year":"2024","unstructured":"Kakoty V et al (2024) Unraveling the role of glial cell line\u2013derived neurotrophic factor in the treatment of parkinson\u2019s disease. Neurol Sci 45(4):1409\u20131418","journal-title":"Neurol Sci"},{"key":"10671_CR74","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.freeradbiomed.2015.08.011","volume":"89","author":"J-I Chuang","year":"2015","unstructured":"Chuang J-I et al (2015) FGF9-induced changes in cellular redox status and HO-1 upregulation are FGFR-dependent and proceed through both ERK and AKT to induce CREB and Nrf2 activation. Free Radic Biol Med 89:274\u2013286","journal-title":"Free Radic Biol Med"},{"issue":"4","key":"10671_CR75","doi-asserted-by":"crossref","first-page":"865","DOI":"10.3390\/cells9040865","volume":"9","author":"L Morel","year":"2020","unstructured":"Morel L et al (2020) Revisiting the role of neurotrophic factors in inflammation. Cells 9(4):865","journal-title":"Cells"},{"issue":"1","key":"10671_CR76","doi-asserted-by":"crossref","first-page":"50","DOI":"10.3390\/ph14010050","volume":"14","author":"A Arranz-Romera","year":"2021","unstructured":"Arranz-Romera A et al (2021) A safe GDNF and GDNF\/BDNF controlled delivery system improves migration in human retinal pigment epithelial cells and survival in retinal ganglion cells: potential usefulness in degenerative retinal pathologies. Pharmaceuticals 14(1):50","journal-title":"Pharmaceuticals"},{"issue":"5","key":"10671_CR77","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.cytogfr.2015.07.007","volume":"26","author":"S Pasquin","year":"2015","unstructured":"Pasquin S, Sharma M, Gauchat J-F (2015) Ciliary neurotrophic factor (CNTF): new facets of an old molecule for treating neurodegenerative and metabolic syndrome pathologies. Cytokine Growth Factor Rev 26(5):507\u2013515","journal-title":"Cytokine Growth Factor Rev"},{"key":"10671_CR78","doi-asserted-by":"crossref","unstructured":"Larsen JV et al (2016) Cytokine-like factor 1, an essential facilitator of cardiotrophin-like cytokine: ciliary neurotrophic factor receptor \u03b1 signaling and sorLA-mediated turnover. Molecular and cellular biology","DOI":"10.1128\/MCB.00917-15"},{"key":"10671_CR79","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.biomaterials.2015.03.028","volume":"55","author":"B Li","year":"2015","unstructured":"Li B et al (2015) PRGD\/PDLLA conduit potentiates rat sciatic nerve regeneration and the underlying molecular mechanism. Biomaterials 55:44\u201353","journal-title":"Biomaterials"},{"issue":"7","key":"10671_CR80","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1007\/s00011-022-01586-y","volume":"71","author":"R Nogueira-Ferreira","year":"2022","unstructured":"Nogueira-Ferreira R et al (2022) Cancer-and cardiac-induced cachexia: same fate through different inflammatory mediators? Inflamm Res 71(7):771\u2013783","journal-title":"Inflamm Res"},{"issue":"9","key":"10671_CR81","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1167\/iovs.63.9.4","volume":"63","author":"K Lee","year":"2022","unstructured":"Lee K et al (2022) Ciliary neurotrophic factor derived from astrocytes protects retinal ganglion cells through PI3K\/AKT, JAK\/STAT, and MAPK\/ERK pathways. Investig Ophthalmol Vis Sci 63(9):4\u20134","journal-title":"Investig Ophthalmol Vis Sci"},{"key":"10671_CR82","doi-asserted-by":"crossref","unstructured":"Kaminska B, Mota M, Pizzi M (2016) Signal transduction and epigenetic mechanisms in the control of microglia activation during neuroinflammation. Biochimica et biophysica acta (BBA)-Molecular basis of disease. 1862(3):339\u2013351","DOI":"10.1016\/j.bbadis.2015.10.026"},{"issue":"4","key":"10671_CR83","first-page":"53","volume":"7","author":"R Bhardwaj","year":"2018","unstructured":"Bhardwaj R, Deshmukh R (2018) Neurotrophic factors and parkinson\u2019s disease. Clin Investig 7(4):53\u201362","journal-title":"Clin Investig"},{"issue":"9","key":"10671_CR84","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1517\/14728220903170675","volume":"13","author":"M Cakir","year":"2009","unstructured":"Cakir M, Grossman AB (2009) Targeting MAPK (Ras\/ERK) and PI3K\/Akt pathways in pituitary tumorigenesis. Expert Opin Ther Targets 13(9):1121\u20131134","journal-title":"Expert Opin Ther Targets"},{"issue":"304","key":"10671_CR85","doi-asserted-by":"crossref","first-page":"ra105","DOI":"10.1126\/scisignal.2004125","volume":"6","author":"E Diaz-Flores","year":"2013","unstructured":"Diaz-Flores E et al (2013) PLC-\u03b3 and PI3K link cytokines to ERK activation in hematopoietic cells with normal and oncogenic Kras. Sci Signal 6(304):ra105\u2013ra105","journal-title":"Sci Signal"},{"issue":"2","key":"10671_CR86","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/s00441-013-1585-y","volume":"353","author":"K Unsicker","year":"2013","unstructured":"Unsicker K (2013) Neurotrophic molecules in the treatment of neurodegenerative disease with focus on the retina: status and perspectives. Cell Tissue Res 353(2):205\u2013218","journal-title":"Cell Tissue Res"},{"key":"10671_CR87","doi-asserted-by":"crossref","first-page":"419042","DOI":"10.3389\/fnins.2018.00834","volume":"12","author":"M Pietrucha-Dutczak","year":"2018","unstructured":"Pietrucha-Dutczak M et al (2018) The role of endogenous neuroprotective mechanisms in the prevention of retinal ganglion cells degeneration. Front NeuroSci 12:419042","journal-title":"Front NeuroSci"},{"issue":"8","key":"10671_CR88","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.3390\/v13081488","volume":"13","author":"A J\u00f3zefiak","year":"2021","unstructured":"J\u00f3zefiak A et al (2021) The IGF-1 signaling pathway in viral infections. Viruses 13(8):1488","journal-title":"Viruses"},{"issue":"10","key":"10671_CR89","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1038\/ncponc0934","volume":"4","author":"Y Tao","year":"2007","unstructured":"Tao Y et al (2007) Mechanisms of disease: signaling of the insulin-like growth factor 1 receptor pathway\u2014therapeutic perspectives in cancer. Nat Clin Pract Oncol 4(10):591\u2013602","journal-title":"Nat Clin Pract Oncol"},{"issue":"2","key":"10671_CR90","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/S0002-9440(10)63311-1","volume":"165","author":"V Poulaki","year":"2004","unstructured":"Poulaki V et al (2004) Insulin-like growth factor-I plays a pathogenetic role in diabetic retinopathy. Am J Pathol 165(2):457\u2013469","journal-title":"Am J Pathol"},{"issue":"8","key":"10671_CR91","doi-asserted-by":"crossref","first-page":"792","DOI":"10.2174\/1570159X14666160813182009","volume":"14","author":"B-S Iwona","year":"2016","unstructured":"Iwona B-S (2016) Growth factors in the pathogenesis of retinal neurodegeneration in diabetes mellitus. Curr Neuropharmacol 14(8):792\u2013804","journal-title":"Curr Neuropharmacol"},{"issue":"27","key":"10671_CR92","doi-asserted-by":"crossref","first-page":"3307","DOI":"10.2174\/092986706778773086","volume":"13","author":"JL Wilkinson-Berka","year":"2006","unstructured":"Wilkinson-Berka JL, Wraight C, Werther G (2006) The role of growth hormone, insulin-like growth factor and somatostatin in diabetic retinopathy. Curr Med Chem 13(27):3307\u20133317","journal-title":"Curr Med Chem"},{"issue":"1","key":"10671_CR93","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/s13098-022-00806-z","volume":"14","author":"T-E Wu","year":"2022","unstructured":"Wu T-E, Chen H-S (2022) The role of growth hormone and IGF-1 in retinopathy: a prospective study of retinopathy in patients with acromegaly and impaired fasting glucose. Diabetol Metab Syndr 14(1):38","journal-title":"Diabetol Metab Syndr"},{"issue":"8","key":"10671_CR94","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1172\/JCI19478","volume":"113","author":"J Ruberte","year":"2004","unstructured":"Ruberte J et al (2004) Increased ocular levels of IGF-1 in Transgenic mice lead to diabetes-like eye disease. J Clin Investig 113(8):1149\u20131157","journal-title":"J Clin Investig"},{"issue":"1","key":"10671_CR95","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.preteyeres.2006.09.002","volume":"26","author":"SX Zhang","year":"2007","unstructured":"Zhang SX, Ma J-x (2007) Ocular neovascularization: implication of endogenous angiogenic inhibitors and potential therapy. Prog Retin Eye Res 26(1):1\u201337","journal-title":"Prog Retin Eye Res"},{"issue":"3","key":"10671_CR96","doi-asserted-by":"crossref","first-page":"392","DOI":"10.4239\/wjd.v15.i3.392","volume":"15","author":"C-Y Zhang","year":"2024","unstructured":"Zhang C-Y, Yang M (2024) Roles of fibroblast growth factors in the treatment of diabetes. World J Diabetes 15(3):392","journal-title":"World J Diabetes"},{"key":"10671_CR97","doi-asserted-by":"crossref","unstructured":"Deng J et al (2021) The multiple roles of fibroblast growth factor in diabetic nephropathy. J Inflamm Res p. 5273\u20135290","DOI":"10.2147\/JIR.S334996"},{"issue":"3","key":"10671_CR98","doi-asserted-by":"crossref","first-page":"618","DOI":"10.3390\/microorganisms9030618","volume":"9","author":"RA Corb Aron","year":"2021","unstructured":"Corb Aron RA et al (2021) Recognizing the benefits of pre-\/probiotics in metabolic syndrome and type 2 diabetes mellitus considering the influence of akkermansia muciniphila as a key gut bacterium. Microorganisms 9(3):618","journal-title":"Microorganisms"},{"issue":"228","key":"10671_CR99","first-page":"pe17","volume":"2004","author":"M Tsang","year":"2004","unstructured":"Tsang M, Dawid IB (2004) Promotion and Attenuation of FGF signaling through the Ras-MAPK pathway. Science\u2019s STKE 2004(228):pe17\u2013pe17","journal-title":"Science\u2019s STKE"},{"issue":"3","key":"10671_CR100","first-page":"104","volume":"19","author":"S Chauhan","year":"2023","unstructured":"Chauhan S et al (2023) Current approaches in healing of wounds in diabetes and diabetic foot ulcers. Curr Bioact Compd 19(3):104\u2013121","journal-title":"Curr Bioact Compd"},{"key":"10671_CR101","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1016\/j.biopha.2018.05.113","volume":"107","author":"G Ye","year":"2018","unstructured":"Ye G et al (2018) Vascular smooth muscle cells activate PI3K\/Akt pathway to attenuate myocardial ischemia\/reperfusion-induced apoptosis and autophagy by secreting bFGF. Biomed Pharmacother 107:1779\u20131785","journal-title":"Biomed Pharmacother"},{"key":"10671_CR102","doi-asserted-by":"crossref","first-page":"118661","DOI":"10.1016\/j.lfs.2020.118661","volume":"264","author":"S Kumar","year":"2021","unstructured":"Kumar S et al (2021) Implicating the effect of ketogenic diet as a preventive measure to obesity and diabetes mellitus. Life Sci 264:118661","journal-title":"Life Sci"},{"issue":"4","key":"10671_CR103","doi-asserted-by":"crossref","first-page":"617","DOI":"10.3390\/cells12040617","volume":"12","author":"P Moustardas","year":"2023","unstructured":"Moustardas P, Aberdam D, Lagali N (2023) MAPK pathways in ocular pathophysiology: potential therapeutic drugs and challenges. Cells 12(4):617","journal-title":"Cells"},{"issue":"3","key":"10671_CR104","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1016\/j.bbrc.2004.08.198","volume":"323","author":"M Abe","year":"2004","unstructured":"Abe M, Naski MC (2004) Regulation of sprouty expression by PLC\u03b3 and calcium-dependent signals. Biochem Biophys Res Commun 323(3):1040\u20131047","journal-title":"Biochem Biophys Res Commun"},{"key":"10671_CR105","doi-asserted-by":"crossref","unstructured":"Subramaniam A et al (2013) Potential role of signal transducer and activator of transcription (STAT) 3 signaling pathway in inflammation, survival, proliferation and invasion of hepatocellular carcinoma. Biochimica et biophysica acta (BBA)-Reviews on Cancer 1835(1):46\u201360","DOI":"10.1016\/j.bbcan.2012.10.002"},{"key":"10671_CR106","doi-asserted-by":"crossref","first-page":"18","DOI":"10.3389\/fendo.2014.00018","volume":"5","author":"H Ohta","year":"2014","unstructured":"Ohta H, Itoh N (2014) Roles of FGFs as adipokines in adipose tissue development, remodeling, and metabolism. Front Endocrinol 5:18","journal-title":"Front Endocrinol"},{"issue":"1","key":"10671_CR107","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/s41392-020-00222-7","volume":"5","author":"Y Xie","year":"2020","unstructured":"Xie Y et al (2020) FGF\/FGFR signaling in health and disease. Signal Transduct Target Therapy 5(1):181","journal-title":"Signal Transduct Target Therapy"},{"key":"10671_CR108","unstructured":"Huttala O (2019) Human In Vitro Vascularization, Adipocytes and Vascularized Adipose Tissue: Three relevant models for studies of vascularization, adipocytes and their interaction"},{"issue":"3","key":"10671_CR109","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1080\/09513590.2021.2005782","volume":"38","author":"F Yilmaz","year":"2022","unstructured":"Yilmaz F, Micili SC, Erbil G (2022) The role of FGF-4 and FGFR-2 on preimplantation embryo development in experimental maternal diabetes. Gynecol Endocrinol 38(3):248\u2013252","journal-title":"Gynecol Endocrinol"},{"key":"10671_CR110","doi-asserted-by":"crossref","unstructured":"Zhang J, Cui C, Xu H, Downregulation of miR-145-5p elevates retinal ganglion cell survival to delay diabetic retinopathy progress by targeting FGF5., Bioscience (2019) Biotechnology, and Biochemistry","DOI":"10.1080\/09168451.2019.1630251"},{"issue":"1","key":"10671_CR111","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s13105-021-00867-0","volume":"78","author":"P Kaur","year":"2022","unstructured":"Kaur P et al (2022) MiRNA signatures in diabetic retinopathy and nephropathy: delineating underlying mechanisms. J Physiol Biochem 78(1):19\u201337","journal-title":"J Physiol Biochem"},{"issue":"11","key":"10671_CR112","doi-asserted-by":"crossref","first-page":"3242","DOI":"10.3390\/cells10113242","volume":"10","author":"M Farooq","year":"2021","unstructured":"Farooq M et al (2021) The role of fibroblast growth factor (FGF) signaling in tissue repair and regeneration. Cells 10(11):3242","journal-title":"Cells"},{"key":"10671_CR113","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/s00441-003-0756-7","volume":"313","author":"B Reuss","year":"2003","unstructured":"Reuss B (2003) Von Bohlen und halbach, fibroblast growth factors and their receptors in the central nervous system. Cell Tissue Res 313:139\u2013157","journal-title":"Cell Tissue Res"},{"key":"10671_CR114","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.cytogfr.2015.10.001","volume":"28","author":"N Itoh","year":"2016","unstructured":"Itoh N, FGF10 (2016) A multifunctional mesenchymal\u2013epithelial signaling growth factor in development, health, and disease. Cytokine Growth Factor Rev 28:63\u201369","journal-title":"Cytokine Growth Factor Rev"},{"key":"10671_CR115","doi-asserted-by":"crossref","first-page":"672935","DOI":"10.3389\/fcell.2021.672935","volume":"9","author":"F Khosravi","year":"2021","unstructured":"Khosravi F et al (2021) The multifunctional contribution of FGF signaling to cardiac development, homeostasis, disease and repair. Front Cell Dev Biology 9:672935","journal-title":"Front Cell Dev Biology"},{"key":"10671_CR116","doi-asserted-by":"crossref","first-page":"830022","DOI":"10.3389\/fendo.2022.830022","volume":"13","author":"X Yu","year":"2022","unstructured":"Yu X et al (2022) The role of fibroblast growth factor 19 subfamily in different populations suffering from osteoporosis. Front Endocrinol 13:830022","journal-title":"Front Endocrinol"},{"key":"10671_CR117","doi-asserted-by":"crossref","first-page":"744868","DOI":"10.3389\/fendo.2021.744868","volume":"12","author":"Y Liu","year":"2021","unstructured":"Liu Y et al (2021) Fibroblast growth factor in diabetic foot ulcer: progress and therapeutic prospects. Front Endocrinol 12:744868","journal-title":"Front Endocrinol"},{"issue":"8","key":"10671_CR118","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.3390\/cells9081755","volume":"9","author":"K Turkowski","year":"2020","unstructured":"Turkowski K et al (2020) Fibroblast growth Factor\u201414 acts as tumor suppressor in lung adenocarcinomas. Cells 9(8):1755","journal-title":"Cells"},{"issue":"2","key":"10671_CR119","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1002\/hep.30810","volume":"71","author":"JD Schumacher","year":"2020","unstructured":"Schumacher JD et al (2020) Direct and indirect effects of fibroblast growth factor (FGF) 15 and FGF19 on liver fibrosis development. Hepatology 71(2):670\u2013685","journal-title":"Hepatology"},{"issue":"1","key":"10671_CR120","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1515\/med-2021-0232","volume":"16","author":"W He","year":"2021","unstructured":"He W et al (2021) FGF16 regulated by miR-520b enhances the cell proliferation of lung cancer. Open Med 16(1):419\u2013427","journal-title":"Open Med"},{"issue":"6","key":"10671_CR121","doi-asserted-by":"crossref","first-page":"701","DOI":"10.3390\/ph17060701","volume":"17","author":"M Kciuk","year":"2024","unstructured":"Kciuk M et al (2024) Exploring the comprehensive neuroprotective and anticancer potential of Afzelin. Pharmaceuticals 17(6):701","journal-title":"Pharmaceuticals"},{"issue":"1","key":"10671_CR122","doi-asserted-by":"crossref","first-page":"6304","DOI":"10.1038\/s41467-023-42058-z","volume":"14","author":"Y Tsuchiya","year":"2023","unstructured":"Tsuchiya Y et al (2023) Fibroblast growth factor 18 stimulates the proliferation of hepatic stellate cells, thereby inducing liver fibrosis. Nat Commun 14(1):6304","journal-title":"Nat Commun"},{"key":"10671_CR123","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2174\/1389201024666230428114740","volume":"25","author":"S Dhankhar","year":"2024","unstructured":"Dhankhar S et al (2024) Unravelling the microbiome\u2019s role in healing diabetic wounds. Curr Pharm Biotechnol 25:1\u201313","journal-title":"Curr Pharm Biotechnol"},{"key":"10671_CR124","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1007\/s13105-019-00675-7","volume":"75","author":"K Dolegowska","year":"2019","unstructured":"Dolegowska K et al (2019) FGF19 subfamily members: FGF19 and FGF21. J Physiol Biochem 75:229\u2013240","journal-title":"J Physiol Biochem"},{"key":"10671_CR125","doi-asserted-by":"crossref","first-page":"111617","DOI":"10.1016\/j.mce.2022.111617","volume":"548","author":"G Guthrie","year":"2022","unstructured":"Guthrie G, Vonderohe C, Burrin D (2022) Fibroblast growth factor 15\/19 expression, regulation, and function: an overview. Mol Cell Endocrinol 548:111617","journal-title":"Mol Cell Endocrinol"},{"issue":"06","key":"10671_CR126","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1055\/a-0623-2909","volume":"50","author":"N Babaknejad","year":"2018","unstructured":"Babaknejad N et al (2018) An overview of FGF19 and FGF21: the therapeutic role in the treatment of the metabolic disorders and obesity. Horm Metab Res 50(06):441\u2013452","journal-title":"Horm Metab Res"},{"issue":"3","key":"10671_CR127","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1038\/s41419-022-04724-w","volume":"13","author":"Y Chen","year":"2022","unstructured":"Chen Y et al (2022) Fibroblast growth factor 20 attenuates pathological cardiac hypertrophy by activating the SIRT1 signaling pathway. Cell Death Dis 13(3):276","journal-title":"Cell Death Dis"},{"issue":"9","key":"10671_CR128","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1038\/s41419-019-1893-6","volume":"10","author":"L Ying","year":"2019","unstructured":"Ying L et al (2019) Fibroblast growth factor 21 ameliorates diabetes-induced endothelial dysfunction in mouse aorta via activation of the CaMKK2\/AMPK\u03b1 signaling pathway. Cell Death Dis 10(9):665","journal-title":"Cell Death Dis"},{"key":"10671_CR129","doi-asserted-by":"crossref","first-page":"18","DOI":"10.3389\/fphar.2020.00018","volume":"11","author":"S Zhu","year":"2020","unstructured":"Zhu S et al (2020) Fibroblast growth factor 22 inhibits ER stress-induced apoptosis and improves recovery of spinal cord injury. Front Pharmacol 11:18","journal-title":"Front Pharmacol"},{"issue":"1","key":"10671_CR130","doi-asserted-by":"crossref","first-page":"4054","DOI":"10.1038\/s41598-024-54788-1","volume":"14","author":"C Oner","year":"2024","unstructured":"Oner C et al (2024) Serum \u03b1-Klotho and fibroblast growth factor 23 levels are not associated with non-proliferative diabetic retinopathy in type 1 diabetes mellitus. Sci Rep 14(1):4054","journal-title":"Sci Rep"},{"key":"10671_CR131","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2174\/221173851201231005143710","volume":"12","author":"R Saharan","year":"2024","unstructured":"Saharan R et al (2024) Hydrogel-based drug delivery system in diabetes management. Pharm Nanatechnol 12:1\u201311","journal-title":"Pharm Nanatechnol"},{"issue":"2","key":"10671_CR132","doi-asserted-by":"crossref","first-page":"241","DOI":"10.2215\/CJN.04250510","volume":"6","author":"SM Titan","year":"2011","unstructured":"Titan SM et al (2011) FGF-23 as a predictor of renal outcome in diabetic nephropathy. Clin J Am Soc Nephrol 6(2):241\u2013247","journal-title":"Clin J Am Soc Nephrol"},{"key":"10671_CR133","doi-asserted-by":"crossref","unstructured":"Mansour SE et al (2020) The evolving treatment of diabetic retinopathy. Clin Ophthalmol p. 653\u2013678","DOI":"10.2147\/OPTH.S236637"},{"issue":"2","key":"10671_CR134","doi-asserted-by":"crossref","first-page":"111","DOI":"10.4103\/ijem.ijem_480_21","volume":"26","author":"BA Mounirou","year":"2022","unstructured":"Mounirou BA et al (2022) Diabetic retinopathy: an overview of treatments. Indian J Endocrinol Metabol 26(2):111\u2013118","journal-title":"Indian J Endocrinol Metabol"},{"issue":"3","key":"10671_CR135","doi-asserted-by":"crossref","first-page":"311","DOI":"10.5114\/ceji.2016.63132","volume":"41","author":"D Po\u017carowska","year":"2016","unstructured":"Po\u017carowska D, Po\u017carowski P (2016) The era of anti-vascular endothelial growth factor (VEGF) drugs in ophthalmology, VEGF and anti-VEGF therapy. Cent Eur J Immunol 41(3):311\u2013316","journal-title":"Cent Eur J Immunol"},{"key":"10671_CR136","unstructured":"LIN K, LU SY (2014) Panretinal navigated laser photocoagulation for PDR. Retina Today p. 65\u201370"},{"issue":"2","key":"10671_CR137","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1007\/s40123-022-00456-4","volume":"11","author":"D Abdulla","year":"2022","unstructured":"Abdulla D et al (2022) The use of sustained release intravitreal steroid implants in non-infectious uveitis affecting the posterior segment of the eye. Ophthalmol Therapy 11(2):479\u2013487","journal-title":"Ophthalmol Therapy"},{"key":"10671_CR138","doi-asserted-by":"crossref","unstructured":"Kaur N, Anti-inflammatory and analgesic activity of curcumin with different NSAIDs(2018). Indian Drugs, 55(7)","DOI":"10.53879\/id.55.07.10632"},{"key":"10671_CR139","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2174\/0102506882253706240104073440","volume":"5","author":"S Rohilla","year":"2024","unstructured":"Rohilla S et al (2024) Anabolic androgenic steroids: A review. New Emirates Med J 5:1\u201310","journal-title":"New Emirates Med J"},{"key":"10671_CR140","doi-asserted-by":"crossref","unstructured":"Gotzaridis EV, Lit ES (2001) and D.J. D\u2019Amico. Progress In vitreoretinal surgery for proliferative diabetic retinopathy. In seminars In ophthalmology. Taylor & Francis","DOI":"10.1076\/soph.16.1.31.4218"},{"key":"10671_CR141","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1146\/annurev-neuro-060909-153227","volume":"33","author":"AN Bramall","year":"2010","unstructured":"Bramall AN et al (2010) The genomic, biochemical, and cellular responses of the retina in inherited photoreceptor degenerations and prospects for the treatment of these disorders. Annu Rev Neurosci 33:441\u2013472","journal-title":"Annu Rev Neurosci"},{"issue":"8","key":"10671_CR142","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1038\/mt.2015.68","volume":"23","author":"DM Lipinski","year":"2015","unstructured":"Lipinski DM et al (2015) CNTF gene therapy confers lifelong neuroprotection in a mouse model of human retinitis pigmentosa. Mol Ther 23(8):1308\u20131319","journal-title":"Mol Ther"},{"key":"10671_CR143","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.jns.2016.02.024","volume":"363","author":"M Afarid","year":"2016","unstructured":"Afarid M, Torabi-Nami M, Zare B (2016) Neuroprotective and restorative effects of the brain-derived neurotrophic factor in retinal diseases. J Neurol Sci 363:43\u201350","journal-title":"J Neurol Sci"},{"issue":"9","key":"10671_CR144","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1161\/CIRCRESAHA.109.199059","volume":"105","author":"JL Kielczewski","year":"2009","unstructured":"Kielczewski JL et al (2009) Insulin-like growth factor binding protein-3 mediates vascular repair by enhancing nitric oxide generation. Circul Res 105(9):897\u2013905","journal-title":"Circul Res"},{"issue":"2","key":"10671_CR145","doi-asserted-by":"crossref","first-page":"022001","DOI":"10.1088\/1748-6041\/8\/2\/022001","volume":"8","author":"NK Mohtaram","year":"2013","unstructured":"Mohtaram NK, Montgomery A, Willerth SM (2013) Biomaterial-based drug delivery systems for the controlled release of neurotrophic factors. Biomed Mater 8(2):022001","journal-title":"Biomed Mater"},{"key":"10671_CR146","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2174\/157341372001230926123938","volume":"20","author":"S Dhankar","year":"2024","unstructured":"Dhankar S et al (2024) A bird view on the role of graphene oxide nanosystems in therapeutic delivery. Curr Nanosci 20:1\u201311","journal-title":"Curr Nanosci"},{"key":"10671_CR147","doi-asserted-by":"crossref","unstructured":"Hammad W et al (2025) Beyond the surface: the role of implantable drug delivery systems in modern medicine. Recent advances in drug delivery and formulation 19:1\u201318","DOI":"10.2174\/0126673878369501250404184028"},{"key":"10671_CR148","doi-asserted-by":"crossref","unstructured":"Mittal P et al (2024) Biobased nanomaterials in biomedical applications, in biobased nanomaterials: applications in biomedicine, food industry, agriculture, and environmental sustainability. Springer, pp 141\u2013171","DOI":"10.1007\/978-981-97-0542-9_6"},{"key":"10671_CR149","doi-asserted-by":"crossref","unstructured":"Nitika G et al (2025) Role of liposomes in the treatment of neurodegenerative disorders: A comprehensive review. Central nervous system agents in medicinal chemistry 25:1\u201317","DOI":"10.2174\/0118715249342585241230065557"},{"key":"10671_CR150","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1016\/j.msec.2017.12.036","volume":"92","author":"D Ding","year":"2018","unstructured":"Ding D, Zhu Q (2018) Recent advances of PLGA micro\/nanoparticles for the delivery of biomacromolecular therapeutics. Mater Sci Engineering: C 92:1041\u20131060","journal-title":"Mater Sci Engineering: C"},{"issue":"4","key":"10671_CR151","doi-asserted-by":"crossref","first-page":"581","DOI":"10.3390\/biom11040581","volume":"11","author":"J Rhee","year":"2021","unstructured":"Rhee J, Shih KC (2021) Use of gene therapy in retinal ganglion cell neuroprotection: current concepts and future directions. Biomolecules 11(4):581","journal-title":"Biomolecules"},{"key":"10671_CR152","unstructured":"Zhu Y et al Integrative kinase activity profiling and phosphoproteomics of retinal explants during cGMP dependent retinal degeneration. Putative role of cGMP-dependent Protein Kinase G in Inherited Retinal Degeneration: Modulators and Biomarkers p. 103"},{"issue":"9","key":"10671_CR153","doi-asserted-by":"crossref","first-page":"4078","DOI":"10.3390\/ijms26094078","volume":"26","author":"I Khan","year":"2025","unstructured":"Khan I et al (2025) Rekindling vision: innovative strategies for treating retinal degeneration. Int J Mol Sci 26(9):4078","journal-title":"Int J Mol Sci"},{"issue":"1","key":"10671_CR154","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1186\/s12886-023-03155-1","volume":"23","author":"MZ Sadikan","year":"2023","unstructured":"Sadikan MZ et al (2023) Diabetic retinopathy: a comprehensive update on in vivo, in vitro and ex vivo experimental models. BMC Ophthalmol 23(1):421","journal-title":"BMC Ophthalmol"},{"key":"10671_CR155","doi-asserted-by":"crossref","unstructured":"Wang J et al (2024) Encapsulated cell technology: delivering cytokines to treat posterior ocular diseases. Pharmacol Res p. 107159","DOI":"10.1016\/j.phrs.2024.107159"},{"issue":"19","key":"10671_CR156","doi-asserted-by":"crossref","first-page":"10334","DOI":"10.3390\/ijms221910334","volume":"22","author":"M Alfonsetti","year":"2021","unstructured":"Alfonsetti M et al (2021) Looking for in vitro models for retinal diseases. Int J Mol Sci 22(19):10334","journal-title":"Int J Mol Sci"},{"key":"10671_CR157","doi-asserted-by":"crossref","first-page":"1416668","DOI":"10.3389\/fendo.2024.1416668","volume":"15","author":"SK Reddy","year":"2024","unstructured":"Reddy SK et al (2024) Cell and molecular targeted therapies for diabetic retinopathy. Front Endocrinol 15:1416668","journal-title":"Front Endocrinol"},{"issue":"3","key":"10671_CR158","doi-asserted-by":"crossref","first-page":"225","DOI":"10.4103\/ijnpnd.ijnpnd_13_21","volume":"11","author":"S Chauhan","year":"2021","unstructured":"Chauhan S et al (2021) Antihyperglycemic and antioxidant potential of plant extract of Litchi chinensis and Glycine max. Int J Nutr Pharmacol Neurol Dis 11(3):225\u2013233","journal-title":"Int J Nutr Pharmacol Neurol Dis"},{"issue":"10","key":"10671_CR159","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1080\/13543784.2022.2113375","volume":"31","author":"MJ Tolentino","year":"2022","unstructured":"Tolentino MJ, Tolentino AJ (2022) Investigational drugs in clinical trials for macular degeneration. Expert Opin Investig Drugs 31(10):1067\u20131085","journal-title":"Expert Opin Investig Drugs"},{"issue":"3","key":"10671_CR160","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.3390\/ijms23031487","volume":"23","author":"PM Pitale","year":"2022","unstructured":"Pitale PM, Gorbatyuk MS (2022) Diabetic retinopathy: from animal models to cellular signaling. Int J Mol Sci 23(3):1487","journal-title":"Int J Mol Sci"},{"key":"10671_CR161","first-page":"100","volume":"10","author":"S Chauhan","year":"2014","unstructured":"Chauhan S et al (2014) Pharmacological evaluation of anti-inflammatory and analgesic potential of Litchi chinensis gaertn.(sonn). Group 10:100","journal-title":"Group"},{"issue":"7","key":"10671_CR162","doi-asserted-by":"crossref","first-page":"775","DOI":"10.3390\/antiox13070775","volume":"13","author":"M Kciuk","year":"2024","unstructured":"Kciuk M et al (2024) Therapeutic potential of plant-Derived compounds and plant extracts in rheumatoid Arthritis\u2014Comprehensive review. Antioxidants 13(7):775","journal-title":"Antioxidants"},{"issue":"19","key":"10671_CR163","doi-asserted-by":"crossref","first-page":"5815","DOI":"10.3390\/jcm13195815","volume":"13","author":"C Henriques","year":"2024","unstructured":"Henriques C et al (2024) Monoclonal antibodies for the treatment of ocular diseases. J Clin Med 13(19):5815","journal-title":"J Clin Med"},{"issue":"1","key":"10671_CR164","doi-asserted-by":"crossref","first-page":"17","DOI":"10.3390\/antiox14010017","volume":"14","author":"Y-J Shen","year":"2024","unstructured":"Shen Y-J, Huang Y-C, Cheng Y-C (2024) Advancements in Antioxidant-Based therapeutics for spinal cord injury: A critical review of strategies and combination approaches. Antioxidants 14(1):17","journal-title":"Antioxidants"},{"issue":"1","key":"10671_CR165","first-page":"3096470","volume":"2020","author":"RR Robles-Rivera","year":"2020","unstructured":"Robles-Rivera RR et al (2020) Adjuvant therapies in diabetic retinopathy as an early approach to delay its progression: the importance of oxidative stress and inflammation. Oxidative Med Cell Longev 2020(1):3096470","journal-title":"Oxidative Med Cell Longev"},{"key":"10671_CR166","doi-asserted-by":"crossref","first-page":"108718","DOI":"10.1016\/j.exer.2021.108718","volume":"210","author":"L Sun","year":"2021","unstructured":"Sun L et al (2021) Single cell RNA sequencing (scRNA-Seq) Deciphering pathological alterations in streptozotocin-induced diabetic retinas. Exp Eye Res 210:108718","journal-title":"Exp Eye Res"},{"issue":"1","key":"10671_CR167","doi-asserted-by":"crossref","first-page":"4902","DOI":"10.1038\/s41467-019-12780-8","volume":"10","author":"M Menon","year":"2019","unstructured":"Menon M et al (2019) Single-cell transcriptomic atlas of the human retina identifies cell types associated with age-related macular degeneration. Nat Commun 10(1):4902","journal-title":"Nat Commun"},{"key":"10671_CR168","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.pneurobio.2018.05.006","volume":"173","author":"G Rathnasamy","year":"2019","unstructured":"Rathnasamy G et al (2019) Retinal microglia\u2013A key player in healthy and diseased retina. Prog Neurobiol 173:18\u201340","journal-title":"Prog Neurobiol"},{"key":"10671_CR169","doi-asserted-by":"crossref","unstructured":"McConnell HL, Mishra A (2022) Cells of the blood\u2013brain barrier: an overview of the neurovascular unit in health and disease. Blood-Brain Barrier: Methods Protocols p. 3\u201324","DOI":"10.1007\/978-1-0716-2289-6_1"},{"issue":"3","key":"10671_CR170","doi-asserted-by":"crossref","first-page":"458","DOI":"10.3390\/jcm10030458","volume":"10","author":"M Mrugacz","year":"2021","unstructured":"Mrugacz M, Bryl A, Zorena K (2021) Retinal vascular endothelial cell dysfunction and neuroretinal degeneration in diabetic patients. J Clin Med 10(3):458","journal-title":"J Clin Med"},{"key":"10671_CR171","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/s43152-020-00014-9","volume":"1","author":"LB Payne","year":"2020","unstructured":"Payne LB et al (2020) Pericytes in vascular development. Curr Tissue Microenvironment Rep 1:143\u2013154","journal-title":"Curr Tissue Microenvironment Rep"},{"key":"10671_CR172","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.preteyeres.2015.06.003","volume":"51","author":"E Vecino","year":"2016","unstructured":"Vecino E et al (2016) Glia\u2013neuron interactions in the mammalian retina. Prog Retin Eye Res 51:1\u201340","journal-title":"Prog Retin Eye Res"},{"key":"10671_CR173","doi-asserted-by":"crossref","first-page":"661938","DOI":"10.3389\/fneur.2021.661938","volume":"12","author":"US Kim","year":"2021","unstructured":"Kim US et al (2021) Retinal ganglion cells\u2014diversity of cell types and clinical relevance. Front Neurol 12:661938","journal-title":"Front Neurol"},{"issue":"1","key":"10671_CR174","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/s13098-024-01282-3","volume":"16","author":"Y Wang","year":"2024","unstructured":"Wang Y et al (2024) Single-cell RNA sequencing reveals roles of unique retinal microglia types in early diabetic retinopathy. Diabetol Metab Syndr 16(1):49","journal-title":"Diabetol Metab Syndr"},{"issue":"1","key":"10671_CR175","doi-asserted-by":"crossref","first-page":"110","DOI":"10.3390\/ijms19010110","volume":"19","author":"C Altmann","year":"2018","unstructured":"Altmann C, Schmidt MH (2018) The role of microglia in diabetic retinopathy: inflammation, microvasculature defects and neurodegeneration. Int J Mol Sci 19(1):110","journal-title":"Int J Mol Sci"},{"issue":"1","key":"10671_CR176","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s40662-021-00239-1","volume":"8","author":"S Nian","year":"2021","unstructured":"Nian S et al (2021) Neurovascular unit in diabetic retinopathy: pathophysiological roles and potential therapeutical targets. Eye Vis 8(1):15","journal-title":"Eye Vis"},{"key":"10671_CR177","doi-asserted-by":"crossref","first-page":"816400","DOI":"10.3389\/fendo.2022.816400","volume":"13","author":"J Yang","year":"2022","unstructured":"Yang J, Liu Z (2022) Mechanistic pathogenesis of endothelial dysfunction in diabetic nephropathy and retinopathy. Front Endocrinol 13:816400","journal-title":"Front Endocrinol"},{"issue":"19","key":"10671_CR178","doi-asserted-by":"crossref","first-page":"7413","DOI":"10.3390\/ijms21197413","volume":"21","author":"H Huang","year":"2020","unstructured":"Huang H (2020) Pericyte-endothelial interactions in the retinal microvasculature. Int J Mol Sci 21(19):7413","journal-title":"Int J Mol Sci"},{"key":"10671_CR179","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.lfs.2016.08.001","volume":"162","author":"FS Sorrentino","year":"2016","unstructured":"Sorrentino FS et al (2016) The importance of glial cells in the homeostasis of the retinal microenvironment and their pivotal role in the course of diabetic retinopathy. Life Sci 162:54\u201359","journal-title":"Life Sci"},{"issue":"4","key":"10671_CR180","doi-asserted-by":"crossref","first-page":"617","DOI":"10.3390\/antiox11040617","volume":"11","author":"R Carpi-Santos","year":"2022","unstructured":"Carpi-Santos R et al (2022) Contribution of M\u00fcller cells in the diabetic retinopathy development: focus on oxidative stress and inflammation. Antioxidants 11(4):617","journal-title":"Antioxidants"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-025-10671-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-025-10671-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-025-10671-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,27]],"date-time":"2025-12-27T16:28:45Z","timestamp":1766852925000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11033-025-10671-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,9]]},"references-count":180,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["10671"],"URL":"https:\/\/doi.org\/10.1007\/s11033-025-10671-4","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,9]]},"assertion":[{"value":"26 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declared no conflict of interest financial or otherwise.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"570"}}